Civica Rx
Civica Rx is a non-profit pharmaceutical company that was established to address the issue of drug shortages and high prices in the United States. The company was founded in 2018 by a consortium of hospitals and health systems, with the goal of ensuring a stable supply of essential generic medications.
History[edit]
Civica Rx was founded in 2018 in response to the growing problem of drug shortages in the United States. The company was initiated by a group of health systems and philanthropies, including the Mayo Clinic, Intermountain Healthcare, and the Laura and John Arnold Foundation. The founding members aimed to create a new model for the production and distribution of generic drugs, focusing on transparency and sustainability.
Mission and Goals[edit]
The primary mission of Civica Rx is to reduce drug shortages and lower the cost of generic medications. The company aims to achieve this by:
- Producing essential generic drugs that are in short supply.
- Offering these drugs at a fair and sustainable price.
- Ensuring a reliable supply chain to prevent future shortages.
Operations[edit]
Civica Rx operates by partnering with contract manufacturers to produce generic drugs. The company focuses on medications that are critical for patient care and have been subject to shortages. By working directly with hospitals and health systems, Civica Rx ensures that its products are distributed efficiently and reach the patients who need them most.
Products[edit]
Civica Rx produces a range of generic medications, including antibiotics, anesthetics, and other essential hospital drugs. The company prioritizes drugs that are frequently in short supply and are vital for patient care.
Impact[edit]
Since its inception, Civica Rx has had a significant impact on the availability and pricing of generic drugs in the United States. By providing a stable supply of essential medications, the company has helped to alleviate drug shortages and reduce costs for hospitals and patients.
Future Plans[edit]
Civica Rx plans to expand its product line and increase its manufacturing capabilities. The company is also exploring partnerships with additional health systems and manufacturers to further its mission of ensuring a reliable supply of affordable generic drugs.
Related pages[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
